Petros Pharmaceuticals, Inc. (PTPI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
애널리스트 추정 주당순이익(EPS) $-53.25 및 매출 $0.01B 다음 회계연도.
주당순이익(EPS) 실적 추이: 2024: 실적 $-0.02 vs 추정 $-53.25 (상회 +100%). 애널리스트 정확도: 0%.
EPS 전망 — PTPI
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$0.02
vs Est –$53.25
▲ 232,432.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
매출 전망 — PTPI
94%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.005B
vs Est $0.005B
▼ 6.3% off
Revenue Trend
Analysts expect stable revenue going forward.
